Welcome to our dedicated page for Fidelis Insurance Holdings SEC filings (Ticker: FIHL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Fidelis Insurance Holdings Limited (FIHL) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures as a foreign private issuer. Fidelis, a Bermuda-headquartered global specialty insurer and reinsurer, files an annual report on Form 20-F and frequent current reports on Form 6-K with the Securities and Exchange Commission. These filings incorporate press releases, consolidated financial statements, management’s discussion and analysis, and investor presentations related to the Group’s Insurance and Reinsurance segments.
Through these documents, investors can review how Fidelis reports segment performance, including gross premiums written, net premiums earned, combined ratios, catastrophe and large losses, and prior-year reserve development for its Insurance and Reinsurance businesses. The filings also describe the impact of specific events, such as California wildfires or aviation-related litigation, on loss ratios and underwriting income.
Fidelis uses its SEC filings to disclose capital management and financing activities, including share repurchase programs, dividend policies and declarations, and the issuance of subordinated notes under an effective shelf registration statement on Form F-3. Certain Form 6-K reports specify that the enclosed financial statements and MD&A are incorporated by reference into the company’s registration statements on Form S-8 and Form F-3.
On Stock Titan, AI-powered tools summarize lengthy FIHL filings so readers can quickly understand key points from Form 20-F and Form 6-K reports, including trends in underwriting performance, capital allocation, and relationships with entities such as The Fidelis Partnership. Users can also track how management commentary and risk disclosures evolve over time across multiple reporting periods.
Because Fidelis is active in specialty insurance and reinsurance, its filings are particularly relevant for those analyzing catastrophe exposure, reserve development, and the interaction between underwriting results, capital markets transactions, and external risk transfer structures such as catastrophe bonds.
Adams Matthew J reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Matthew J. Adams received an equity grant of 6,517 common shares in the form of restricted share units. The grant was made at no cash cost per share and is subject to time-based vesting conditions. After this award, Adams directly holds 22,548 common shares, including the new RSUs, each representing a contingent right to receive one common share upon vesting.
Strickle Jonathan reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd Group Managing Director Jonathan Strickle received a grant of 71,725 common shares as equity compensation. The shares were awarded at no cash cost to him. Following this grant, he directly holds 140,186 common shares.
This total includes 123,806 restricted share units that are subject to time-based vesting conditions, each representing a contingent right to receive one common share when vesting requirements are met.
Pearson Michael Justin reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd reported that Chief Risk Officer Michael Justin Pearson received a grant of 33,107 common shares on March 30, 2026 at no cash cost per share. Following this award, he directly holds 187,568 common shares, including 74,103 restricted share units subject to time-based vesting conditions.
Kittinger Jason Allen reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd Chief Operating Officer Jason Allen Kittinger received a grant of 37,682 common shares on this Form 4 event, at a stated price of $0.0000 per share, indicating a share award rather than a market purchase. Following this grant, he directly holds 68,409 common shares. A footnote explains that this figure includes 60,908 restricted share units subject to time-based vesting conditions, each representing a contingent right to receive one common share upon vesting.
Iberg Cathleen Ann reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Cathleen Ann Iberg received an equity award of 6,517 common shares on a grant/award basis, with no cash paid per share. This award consists of 6,517 restricted share units subject to time-based vesting, each convertible into one common share upon vesting. Following this grant, she holds a total of 26,026 common shares and restricted share units directly, reflecting routine, compensation-related equity rather than an open‑market purchase or sale.
Dandridge Christine Elaine reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Christine Elaine Dandridge received an equity grant of 6,517 common shares as a stock award. The Form 4 shows these are restricted share units subject to time-based vesting, with each unit deliverable as one common share when it vests and no cash purchase price. Following this grant, Dandridge’s direct holdings reported in the filing total 19,618 common shares, reflecting a routine compensation-related award rather than an open-market share purchase or sale.
Fidelis Insurance Holdings Ltd director equity grant: Director Collis Charles Grant Ross received an award of 6,517 common shares in the form of restricted share units at a price of $0.00 per share as compensation. These RSUs are subject to time-based vesting, and each unit converts into one common share upon vesting. Following this award, Ross directly holds 11,948 common shares, reflecting a routine, non‑market equity compensation grant rather than an open‑market purchase.
Fidelis Insurance Holdings Ltd reported that its Chief Financial Officer, Allan Carl Decleir, acquired 19,520 common shares as a grant or award on March 30, 2026 at a stated price of $0.00 per share. After this compensation-related award, he directly holds 191,919 common shares. This direct position includes 89,790 restricted share units (RSUs) that are subject to time-based vesting conditions, with each RSU representing a contingent right to receive one common share upon vesting.
Fidelis Insurance Holdings Ltd reported that Chief Executive Officer Daniel David Burrows acquired 154,170 common shares as a grant at a stated price of $0.00 per share, reflecting equity compensation rather than an open‑market purchase. Following this award, he directly holds 715,523 common shares. This total includes 295,345 restricted share units (RSUs) that are subject to time-based vesting conditions, each representing a contingent right to receive one common share when vesting requirements are met.
Morrissey Helena reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Helena Morrissey received an equity award of 7,820 Common Shares on March 30, 2026. The award was granted at no cash cost per share and is part of her director compensation.
According to the footnote, the award consists of 7,280 restricted share units that are subject to time-based vesting conditions, with each unit convertible into one common share upon vesting. Following this grant, Morrissey holds 7,820 common shares directly.